Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma

Published:2021-05-24 Issue:1 Volume:22 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Guo Jingjing¹,Wang Saixia²,Han Yujing³,Jia Zhongyuan⁴,Wang Runchao³

Affiliation:

1. Interventional Department of Liver Diseases, Qingdao Sixth People's Hospital, Qingdao, Shandong 266000, P.R. China

2. Integrated Outpatient Department, Qingdao Sixth People's Hospital, Qingdao, Shandong 266000, P.R. China

3. Integrated Traditional Chinese Medicine and Western Medicine Department, Qingdao Sixth People's Hospital, Qingdao, Shandong 266000, P.R. China

4. Department of General Practice, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan Maternity and Child Care Hospital, Jinan, Shandong 250000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-07-15

2. Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study;Journal of Hepatocellular Carcinoma;2024-06

3. The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications;British Journal of Cancer;2024-05-17

4. Comparison of tumor response and outcomes of patients with hepatocellular carcinoma after multimodal treatment including immune checkpoint inhibitors – a systematic review and meta-analysis;HPB;2024-05

5. Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure;Life Sciences;2024-04